Featured Content

Articles

Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its 4-week and 8-week blood glucose results from its WEIGHT-A24-1 animal study (the “study”). This study will examine diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and DehydraTECH-processed cannabidiol, alone and in combination . The ongoing study uses diabetic, pre-conditioned Zucker … Continue reading “Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study”

TinyGemsBreaks

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). “Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D … Continue reading “TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program”

Sector News

Filter Releases
Sectors



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}

NewsRoom

Receive Alerts from TinyGems

Text "Gems" to 888-902-4192

(US Mobile Phones Only)

About TinyGems

Discover diamonds in the rough with TinyGems.

TinyGems spotlights emergent small-cap companies with bright futures and big potential. Small and yet unproven, there’s obvious risk but also huge upside possibilities for investors in the know. Contrary to conventional dogma, shares of small-cap and mid-cap companies posted far superior total returns than mega-cap stocks since December 1999.

Don’t overlook the innovation of disruptive small-cap companies on the cusp of market discovery. TinyGems puts a spotlight on the best and brightest of these disruptors that have the technology, the talent, the drive, and the business models to make a huge impact in the markets and in portfolios.

More About TinyGems    Schedule a Live Online Demo

Contact us: (310) 299-1717